Highlighting results from first FDA-reported study for treatment of presbyopia
Season 2, Episode 1, Sep 27, 2021, 04:21 AM
George O. Waring IV, MD, FACS, discusses the latest results from the GEMINI 1 clinical trial (by Allergan, an Abbvie company) of AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia.